[1] CROWELL A, GWATHMEY K G. Sensory neuronopathies[J]. Curr Neurol Neurosci Rep, 2017, 17(10): 79.
[2] CAMDESSANCHÉ J P, JOUSSERAND G, FERRAUD K, et al.The pattern and diagnostic criteria of sensory neuronopathy:a case-control study[J]. Brain, 2009, 132(Pt 7): 1723-1733.
[3] 卢如意, 章殷希, 丁美萍. 感觉神经元病的临床诊治研究进展[J]. 中国临床神经科学, 2015, 23(2): 217-221.
[4] CRÉANGE A. Guillain-Barre syndrome:100 years on[J]. Rev Neurol (Paris), 2016, 172(12): 770-774.
[5] KAZARIAN M, LAIRD-OFFRINGA I A. Small-cell lung cancer-associated autoantibodies: potential applications to cancer diagnosis, early detection, and therapy [J]. Mol Cancer, 2011, 10:33.
[6] SENTIES-MADRID H, VEGA-BOADA F. Paraneoplastic syndromes associated with anti-Hu antibodies[J]. Isr Med Assoc J, 2001, 3(2): 94-103.
[7] GWATHMEY K G. Sensory neuronopathies[J]. Muscle Nerve, 2016, 53(1): 8-19.
[8] 周立新, 关鸿志, 刘洪生, 等. 小细胞肺癌相关神经副肿瘤综合征的临床特点及治疗[J]. 中华医学杂志, 2015, 95(37): 3023-3026.
[9] 王刚, 陈齐鸣, 祝延, 等. 特异性神经元抗Hu抗体对小细胞肺癌早期诊断价值的研究[J]. 中华结核和呼吸杂志, 2002, 25(12): 31-34.
[10]GRAUS F, DELATTRE J Y, ANTOINE J C, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes[J]. J Neurol Neurosurg Psychiatry, 2004, 75(8): 1135-1140. |
